Genoil (GNOLF) Enterprise Value (2009 - 2025)

Genoil (GNOLF) has reported Enterprise Value for 15 consecutive years, with $6.1 million the latest figure, recorded in Q4 2025.

• On a quarterly basis, Enterprise Value fell 68.93% year-over-year to $6.1 million in Q4 2025; TTM through Dec 2025 was $6.1 million, a 68.93% decrease from a year earlier, with the FY2025 full-year figure at $6.1 million, down 68.93% from the prior year.
• Enterprise Value was $6.1 million for Q4 2025 at Genoil, down from $39.4 million in the prior quarter.
• Over five years, Enterprise Value peaked at $39.4 million in Q3 2025 and troughed at $6.0 million in Q3 2021.
• A 3-year average of $15.3 million and a median of $13.0 million in 2021 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value rose 9.03% in 2021 and plunged 68.93% in 2025, its largest moves.
• Over 3 years, Enterprise Value stood at $6.4 million in 2021, then soared by 207.22% to $19.7 million in 2024, then sank by 68.93% to $6.1 million in 2025.
• The last three Enterprise Value figures came in at $6.1 million (Q4 2025), $39.4 million (Q3 2025), and $19.7 million (Q2 2025), per Business Quant data.